Mediator Subunit Med15 Regulates Cell Morphology and Mating in Candida lusitaniae

Candida lusitaniae is an emerging opportunistic pathogenic yeast capable of shifting from yeast to pseudohyphae form, and it is one of the few Candida species with the ability to reproduce sexually. In this study, we showed that a dpp3Δ mutant, inactivated for a putative pyrophosphatase, is impaired in cell separation, pseudohyphal growth and mating. The defective phenotypes were not restored after the reconstruction of a wild-type DPP3 locus, reinforcing the hypothesis of the presence of an additional mutation that we suspected in our previous study. Genetic crosses and genome sequencing identified an additional mutation in MED15, encoding a subunit of the mediator complex that functions as a general transcriptional co-activator in Eukaryotes. We confirmed that inactivation of MED15 was responsible for the defective phenotypes by rescuing the dpp3Δ mutant with a wild-type copy of MED15 and constructing a med15Δ knockout mutant that mimics the phenotypes of dpp3Δ in vitro. Proteomic analyses revealed the biological processes under the control of Med15 and involved in hyphal growth, cell separation and mating. This is the first description of the functions of MED15 in the regulation of hyphal growth, cell separation and mating, and the pathways involved in C. lusitaniae.

[1]  Thomas M. Keane,et al.  Twelve years of SAMtools and BCFtools , 2020, GigaScience.

[2]  Duncan W. Wilson,et al.  Characterization of a Candida albicans Mutant Defective in All MAPKs Highlights the Major Role of Hog1 in the MAPK Signaling Network , 2020, Journal of fungi.

[3]  T. Gabaldón,et al.  The Quiet and Underappreciated Rise of Drug-Resistant Invasive Fungal Pathogens , 2020, Journal of fungi.

[4]  Yasset Perez-Riverol,et al.  The ProteomeXchange consortium in 2020: enabling ‘big data’ approaches in proteomics , 2019, Nucleic Acids Res..

[5]  S. Kelly,et al.  Comparative Genomics for the Elucidation of Multidrug Resistance in Candida lusitaniae , 2019, mBio.

[6]  A. Zorzano,et al.  Metabolic implications of organelle–mitochondria communication , 2019, EMBO reports.

[7]  J. Fassler,et al.  Med15: Glutamine-Rich Mediator Subunit with Potential for Plasticity. , 2019, Trends in biochemical sciences.

[8]  T. Boekhout,et al.  The changing spectrum of Saccharomycotina yeasts causing candidemia: phylogeny mirrors antifungal susceptibility patterns for azole drugs and amphothericin B. , 2019, FEMS yeast research.

[9]  Ronald N. Jones,et al.  Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997–2016 , 2019, Open forum infectious diseases.

[10]  The UniProt Consortium,et al.  UniProt: a worldwide hub of protein knowledge , 2018, Nucleic Acids Res..

[11]  M. Biran,et al.  Glycerol supports growth of the Trypanosoma brucei bloodstream forms in the absence of glucose: Analysis of metabolic adaptations on glycerol-rich conditions , 2018, PLoS pathogens.

[12]  J. Soutourina Transcription regulation by the Mediator complex , 2017, Nature Reviews Molecular Cell Biology.

[13]  N. Biteau,et al.  Genome Sequence of the Yeast Clavispora lusitaniae Type Strain CBS 6936 , 2017, Genome Announcements.

[14]  Liming Liu,et al.  Med15B Regulates Acid Stress Response and Tolerance in Candida glabrata by Altering Membrane Lipid Composition , 2017, Applied and Environmental Microbiology.

[15]  R. Bennett,et al.  Development of a CRISPR-Cas9 System for Efficient Genome Editing of Candida lusitaniae , 2017, mSphere.

[16]  A. Tyagi,et al.  Emerging functions of multi-protein complex Mediator with special emphasis on plants , 2017, Critical reviews in biochemistry and molecular biology.

[17]  A. Chowdhary,et al.  Candida auris: A rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally , 2017, PLoS pathogens.

[18]  D. MacCallum,et al.  Amplification of TLO Mediator Subunit Genes Facilitate Filamentous Growth in Candida Spp. , 2016, PLoS genetics.

[19]  O. Jousson,et al.  Age and Gender Affect the Composition of Fungal Population of the Human Gastrointestinal Tract , 2016, Front. Microbiol..

[20]  Maurizio Sanguinetti,et al.  Inhibiting Fungal Multidrug Resistance by Disrupting an Activator-Mediator Interaction , 2016, Nature.

[21]  J. Berman,et al.  Telomeric ORFS in Candida albicans: Does Mediator Tail Wag the Yeast? , 2015, PLoS pathogens.

[22]  B. Kullberg,et al.  Invasive Candidiasis. , 2015, The New England journal of medicine.

[23]  Matthew Z. Anderson,et al.  Telomeric ORFs (TLOs) in Candida spp. Encode Mediator Subunits That Regulate Distinct Virulence Traits , 2014, PLoS genetics.

[24]  D. Brèthes,et al.  Deletion of the Uracil Permease Gene Confers Cross-Resistance to 5-Fluorouracil and Azoles in Candida lusitaniae and Highlights Antagonistic Interaction between Fluorinated Nucleotides and Fluconazole , 2014, Antimicrobial Agents and Chemotherapy.

[25]  N. Xu,et al.  The type II Ca2+/calmodulin-dependent protein kinases are involved in the regulation of cell wall integrity and oxidative stress response in Candida albicans. , 2014, Biochemical and biophysical research communications.

[26]  R. Bennett,et al.  Convergent Evolution of a Fused Sexual Cycle Promotes the Haploid Lifestyle , 2014, Nature.

[27]  David R. Soll,et al.  The role of phenotypic switching in the basic biology and pathogenesis of Candida albicans , 2014, Journal of oral microbiology.

[28]  T. Calandra,et al.  Invasive candidiasis as a cause of sepsis in the critically ill patient , 2013, Virulence.

[29]  Jef D Boeke,et al.  Genome-wide consequences of deleting any single gene. , 2013, Molecular cell.

[30]  J. Bessoule,et al.  Host-Pathogen Interaction and Signaling Molecule Secretion Are Modified in the dpp3 Knockout Mutant of Candida lusitaniae , 2013, Infection and Immunity.

[31]  Anda Zhang,et al.  Differential Regulation of White-Opaque Switching by Individual Subunits of Candida albicans Mediator , 2013, Eukaryotic Cell.

[32]  Heng Li Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM , 2013, 1303.3997.

[33]  C. D. de Koster,et al.  Surface stress induces a conserved cell wall stress response in the patho- genic fungus Candida albicans , 2013 .

[34]  R. Morse,et al.  Selective role of Mediator tail module in the transcription of highly regulated genes in yeast , 2012, Transcription.

[35]  Pablo Cingolani,et al.  © 2012 Landes Bioscience. Do not distribute. , 2022 .

[36]  J. Benschop,et al.  Distinct role of Mediator tail module in regulation of SAGA‐dependent, TATA‐containing genes in yeast , 2012, The EMBO journal.

[37]  S. El-Kirat-Chatel,et al.  A two‐step cloning‐free PCR‐based method for the deletion of genes in the opportunistic pathogenic yeast Candida lusitaniae , 2011, Yeast.

[38]  M. Crouzet,et al.  The Candida albicans Rgd1 is a RhoGAP protein involved in the control of filamentous growth. , 2010, Fungal genetics and biology : FG & B.

[39]  K. Oh,et al.  Candida albicans PHO81 is required for the inhibition of hyphal development by farnesoic acid , 2010, FEBS letters.

[40]  Sohail Malik,et al.  The metazoan Mediator co-activator complex as an integrative hub for transcriptional regulation , 2010, Nature Reviews Genetics.

[41]  M. Arendrup Epidemiology of invasive candidiasis , 2010, Current opinion in critical care.

[42]  M. DePristo,et al.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.

[43]  Alexander D. Johnson,et al.  A Phenotypic Profile of the Candida albicans Regulatory Network , 2009, PLoS genetics.

[44]  A. Hinnebusch,et al.  Activator Gcn4 Employs Multiple Segments of Med15/Gal11, Including the KIX Domain, to Recruit Mediator to Target Genes in Vivo*♦ , 2009, The Journal of Biological Chemistry.

[45]  J. Heitman,et al.  Mechanistic Plasticity of Sexual Reproduction and Meiosis in the Candida Pathogenic Species Complex , 2009, Current Biology.

[46]  Fajun Yang,et al.  Mediator Subunit Gal11p/MED15 Is Required for Fatty Acid-dependent Gene Activation by Yeast Transcription Factor Oaf1p* , 2009, Journal of Biological Chemistry.

[47]  M. Dunham,et al.  Fis1 deficiency selects for compensatory mutations responsible for cell death and growth control defects , 2008, Cell Death and Differentiation.

[48]  H. Bourbon,et al.  Comparative genomics supports a deep evolutionary origin for the large, four-module transcriptional mediator complex , 2008, Nucleic acids research.

[49]  T. Calandra,et al.  Bench-to-bedside review: Candida infections in the intensive care unit , 2008, Critical care.

[50]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[51]  William Stafford Noble,et al.  Semi-supervised learning for peptide identification from shotgun proteomics datasets , 2007, Nature Methods.

[52]  K. Nickerson,et al.  Effect of Farnesol on a Mouse Model of Systemic Candidiasis, Determined by Use of a DPP3 Knockout Mutant of Candida albicans , 2007, Infection and Immunity.

[53]  M. Pfaller,et al.  Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem , 2007, Clinical Microbiology Reviews.

[54]  John S. Satterlee,et al.  An ARC/Mediator subunit required for SREBP control of cholesterol and lipid homeostasis , 2006, Nature.

[55]  K. Yamamoto,et al.  A Mediator subunit, MDT-15, integrates regulation of fatty acid metabolism by NHR-49-dependent and -independent pathways in C. elegans. , 2006, Genes & development.

[56]  Bethann S. Hromatka,et al.  Transcriptional response of Candida albicans to nitric oxide and the role of the YHB1 gene in nitrosative stress and virulence. , 2005, Molecular biology of the cell.

[57]  K. Nickerson,et al.  Farnesol Concentrations Required To Block Germ Tube Formation in Candida albicans in the Presence and Absence of Serum , 2005, Applied and Environmental Microbiology.

[58]  F. Klis,et al.  Granulocytes govern the transcriptional response, morphology and proliferation of Candida albicans in human blood , 2005, Molecular microbiology.

[59]  A. Favel,et al.  Differentiation between Atypical Isolates of Candida lusitaniae and Candida pulcherrima by Determination of Mating Type , 2005, Journal of Clinical Microbiology.

[60]  J. Villard,et al.  Development of an integrative transformation system for the opportunistic pathogenic yeast Candida lusitaniae using URA3 as a selection marker , 2004, Yeast.

[61]  Y. Nogi,et al.  A novel mutation that affects utilization of galactose in Saccharomyces cerevisiae , 1980, Current Genetics.

[62]  J. Villard,et al.  Selection and genetic analysis of pseudohyphae defective mutants with attenuated virulence in Candida Lusitaniae , 2004 .

[63]  A. Favel,et al.  Colony morphology switching of Candida lusitaniae and acquisition of multidrug resistance during treatment of a renal infection in a newborn: case report and review of the literature. , 2003, Diagnostic microbiology and infectious disease.

[64]  L. Baddour,et al.  Candida lusitaniae infections in the era of fluconazole availability. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[65]  A. Favel,et al.  Alternative Identification Test Relying upon Sexual Reproductive Abilities of Candidalusitaniae Strains Isolated from Hospitalized Patients , 2001, Journal of Clinical Microbiology.

[66]  K. Nickerson,et al.  Quorum Sensing in the Dimorphic FungusCandida albicans Is Mediated by Farnesol , 2001, Applied and Environmental Microbiology.

[67]  I. Raad,et al.  Candida lusitaniae: a cause of breakthrough fungemia in cancer patients. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[68]  J. Heitman,et al.  A STE12 homolog is required for mating but dispensable for filamentation in candida lusitaniae. , 2000, Genetics.

[69]  K. Hazen,et al.  New and emerging yeast pathogens , 1995, Clinical microbiology reviews.

[70]  D. Pappagianis,et al.  Development of Resistance to Amphotericin B in Candida lusitaniae Infecting a Human , 1979, Antimicrobial Agents and Chemotherapy.